Fosun Prices Hong Kong IPO at Bottom of the Range
Shanghai Fosun Pharma priced its Hong Kong IPO at the bottom of the announced price range, giving the transaction a value of $512 million – it was expected to raise $600 million. The price is a 13% discount from the shares on the Shanghai exchange. The offering was over-subscribed by a factor of two, but many of the institutional investors put in their bids at the bottom of the range, keeping a lid of the price. If the underwriters’ overallotment is exercised, the IPO will raise an additional $76.7 million. More details.... Stock Symbols: (SHA: 600196; HK: 2196) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});  
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here